Amplexa Genetics A/S retweeted
Paper out🚨
Can we use #PrecisionMedicine🧬after #Epilepsy surgery?
🔍Here we show for the 1st time that treatment with #galactose might improve seizure/cognitive outcomes after surgery in cases with #MOGHE / somatic #SLC35A2 🧠
Full text➡️ rdcu.be/ddVgK
Celebrating #InternationalEpilepsyDay! Raising awareness for the impact epilepsy has on millions worldwide. Precise genetic testing is crucial for accurate diagnosis & treatment. Join us in supporting the fight with our comprehensive #EPIDASD panel. #AmplexaGenetics #Epilepsy
54
New year, new projects💪 - new, cutting-edge techniques!🧬
✔️ We use #10xGenomics to provide high quality #scRNAseq and #scATACseq data to all kinds of #ResearchProjects
✔️ We provide full #dataanalysis and #ReadyToPublish figures, if you don't have an in-house #bioinformatician
48
Amplexa Genetics A/S retweeted
An editorial in @naturemethods reports that the journal has chosen long-read sequencing, which allows for a more complete reading of genomic information, as its Method of the Year for 2022. go.nature.com/3QEqG8u
Amplexa Genetics A/S retweeted
For #EpilepsyDay 2023, we are spreading the truth about #epilepsy! Did you know that epilepsy is not just one disorder? #EpilepsyIs - or epilepsies are - many diverse syndromes with the common element of seizures. internationalepilepsyday.org
#StampOutStigma @IBESocialMedia @yesILAE
#LongReadSequencing - Method of the year 2022 is used by #Amplexa!💪
We perform long-read sequencing by using Oxford Nanopore Technologies for #StructuralVariant, over #WholeGenomeSequencing to #Microbiomes and detection of base modification.
Contact us for more information!
54
Amplexa Genetics A/S retweeted
Congratulation to @AndreasDamgaar5 with his new title Master of Science, after defending his thesis 'Investigating bacteriophage resistance mechanisms in 𝑃𝑠𝑒𝑢𝑑𝑜𝑚𝑜𝑛𝑎𝑠 𝑎𝑒𝑟𝑢𝑔𝑖𝑛𝑜𝑠𝑎'. Thanks to @ClareLKirkpatr1 and Mogens Kilstrup for great scientific discussions!










